phagocytosi
rafteri
howev
neutrophil
anoth
much
less
recogn
mean
kill
pathogen
format
net
brinkmann
et
al
net
weblik
structur
dna
protein
expel
neutrophil
ensnar
pathogen
fig
expel
dna
extracellular
space
wide
recogn
critic
immun
function
yet
even
plant
special
cell
kill
soil
pathogen
mechan
wen
et
al
net
format
regul
process
although
signal
involv
incomplet
understood
key
enzym
format
net
neutrophil
elastas
ne
degrad
intracellular
protein
trigger
nuclear
disintegr
peptidyl
arginin
deiminas
type
citrullin
histon
facilit
decondens
releas
chromosom
dna
gasdermin
gener
pore
membran
neutrophil
therebi
facilit
cell
membran
ruptur
expuls
dna
associ
molecul
kaplan
radic
papayannopoulo
papayannopoulo
et
al
rohrbach
et
al
sollberg
et
al
although
net
benefici
host
defens
pathogen
collater
damag
sustain
net
format
also
stimul
mani
diseas
process
includ
occur
viral
infect
rafteri
inde
excess
net
format
trigger
cascad
inflammatori
reaction
promot
cancer
cell
metastasi
destroy
surround
tissu
facilit
microthrombosi
result
perman
organ
damag
pulmonari
cardiovascular
renal
system
jorch
kube
kessenbrock
et
al
papayannopoulo
fig
importantli
three
commonli
affect
organ
system
sever
bonow
et
al
chen
et
al
prior
report
extens
link
aberr
net
format
pulmonari
diseas
particularli
ard
inde
net
level
plasma
higher
patient
transfusionassoci
ard
subject
without
ard
caudrilli
et
al
furthermor
neutrophil
patient
pneumoniaassoci
ard
appear
prime
form
net
extent
prime
level
net
blood
correl
diseas
sever
mortal
adrov
et
al
bendib
et
al
ebrahimi
et
al
et
al
mikacen
et
al
extracellular
histon
like
partli
origin
net
elev
bronchoalveolar
lavag
fluid
plasma
ard
patient
lv
et
al
nake
histon
toxic
cell
strong
experiment
evid
support
role
histon
ard
sepsi
wygrecka
et
al
figur
neutrophil
autopsi
specimen
lung
patient
succumb
extens
neutrophil
infiltr
pulmonari
capillari
acut
capillar
fibrin
deposit
extravas
alveolar
space
imag
chosen
emphas
capillari
lesion
b
neutrophil
mucos
trachea
entir
airway
affect
imag
borczuk
weill
cornel
medic
center
specimen
origin
male
hispan
decent
diabet
endstag
renal
diseas
hemodialysi
heart
failur
hepat
c
ledipasvirsofosbuvir
therapi
declin
medic
intervent
therefor
intub
die
emerg
room
h
present
shortli
develop
fever
evid
sepsi
patient
clinic
premortem
cultur
neg
autopsi
perform
within
h
death
similar
neutrophil
distribut
less
extens
infiltr
observ
two
addit
autopsi
analyz
date
two
case
longer
durat
symptom
scale
bar
excess
net
format
drive
varieti
sever
patholog
lung
net
drive
accumul
mucu
cf
patient
airway
net
also
drive
ard
varieti
induc
includ
influenza
vascular
system
net
drive
atherosclerosi
aortic
aneurysm
well
thrombosi
particularli
microthrombosi
devast
effect
organ
function
xu
et
al
therefor
like
net
sourc
extracellular
histon
contribut
ard
sepsi
chaput
zychlinski
looney
xu
et
al
anim
model
lung
injuri
net
develop
respons
varieti
ardsinduc
stimuli
prevent
dissolv
net
reduc
lung
injuri
increas
surviv
caudrilli
et
al
et
al
liu
et
al
narasaraju
et
al
mucou
secret
found
airway
patient
mao
et
al
preprint
reminisc
seen
cf
patient
et
al
caus
origin
secret
unclear
howev
cf
mucou
secret
impair
ga
exchang
shown
contain
extracellular
dna
part
origin
net
releas
respons
persist
lung
infect
furthermor
excess
format
net
increas
ne
make
mucu
thick
viscou
manzenreit
et
al
impair
ventil
also
facilit
colon
bacteria
colon
promot
neutrophil
recruit
net
format
increas
mucu
viscos
consequ
lower
patient
respiratori
function
mucou
secret
contain
net
may
play
similar
role
cf
impair
ga
exchang
facilit
secondari
infect
net
excess
thrombosi
acut
cardiac
kidney
injuri
common
patient
sever
contribut
mortal
diseas
bonow
et
al
ddimer
fibrin
degrad
product
indic
hyperact
coagul
emerg
reliabl
marker
sever
high
blood
level
net
may
explain
find
intravascular
net
shown
play
vital
role
initi
accret
thrombosi
arteri
vein
exampl
sever
coronari
arteri
diseas
complex
net
elev
net
level
posit
associ
thrombin
level
predict
advers
cardiac
event
borissoff
et
al
addit
autopsi
sampl
collect
septic
patient
show
net
infiltr
microthrombi
et
al
thu
net
circul
high
level
blood
trigger
occlus
small
vessel
lead
damag
lung
heart
kidney
cederval
et
al
fuch
et
al
laridan
et
al
martinod
wagner
mous
model
septicemia
intravascular
net
form
microthrombi
obstruct
blood
vessel
caus
damag
lung
liver
organ
et
al
mechanist
net
activ
contact
pathway
coagul
also
call
plasma
kallikreinkinin
system
via
electrostat
interact
net
histon
platelet
phospholipid
oehmck
et
al
histon
also
promot
platelet
activ
act
ligand
tolllik
receptor
platelet
semeraro
et
al
time
ne
bound
activ
form
net
like
also
play
import
role
digest
major
coagul
inhibitor
antithrombin
iii
tissu
factor
pathway
inhibitor
massberg
et
al
furthermor
almost
sure
feedback
loop
wherebi
procoagul
activ
eg
thrombin
lead
platelet
activ
activ
platelet
enhanc
net
format
caudrilli
et
al
clark
et
al
fuch
et
al
massberg
et
al
sreeramkumar
et
al
von
et
al
dissolv
net
dnase
restor
normal
perfus
heart
kidney
microvasculatur
anim
model
cederval
et
al
jansen
et
al
nakazawa
et
al
raupkonsavag
et
al
base
find
argu
target
intravascular
net
may
similarli
reduc
thrombosi
patient
sever
sever
associ
cytokin
storm
character
increas
plasma
concentr
protein
monocyt
chemoattract
protein
gcsf
macrophag
inflammatori
protein
mehta
et
al
ruan
et
al
wu
yang
zhang
et
al
inflammatori
mediat
regul
neutrophil
activ
induc
express
chemoattract
molecul
increas
traffick
neutrophil
site
inflamm
moreov
cytokin
storm
lead
acut
lung
injuri
ard
death
channappanavar
perlman
chousterman
et
al
especi
noteworthi
net
induc
macrophag
secret
enhanc
net
format
variou
diseas
includ
aortic
aneurysm
atherosclerosi
kahlenberg
et
al
meher
et
al
sil
et
al
warnatsch
et
al
togeth
data
suggest
condit
normal
signal
dampen
inflamm
lost
cytokin
storm
signal
loop
macrophag
neutrophil
lead
uncontrol
progress
inflamm
inde
correl
net
exist
sever
asthma
lachowiczscroggin
et
al
loop
activ
sever
acceler
product
net
could
acceler
respiratori
decompens
format
microthrombi
aberr
immun
respons
importantli
induc
dinarello
emerg
promis
target
treatment
mehta
et
al
xu
et
al
preprint
signal
via
classic
transsign
calabres
rosejohn
classic
signal
bind
complex
transmembran
receptor
common
cytokin
receptor
transsign
solubl
bind
initi
signal
via
transsign
strongli
associ
proinflammatori
state
calabres
rosejohn
lower
level
associ
better
lung
function
eg
asthma
ferreira
et
al
hawkin
et
al
neutrophil
shed
respons
marin
et
al
abund
cytokin
storm
wu
yang
zhang
et
al
togeth
find
lead
us
specul
antagon
transsign
andor
could
effect
indirect
strategi
target
neutrophil
net
sever
due
clear
similar
clinic
present
sever
known
netopathiesard
microthrombosisw
propos
excess
net
may
play
major
role
diseas
understand
net
format
function
incomplet
drug
target
net
exist
develop
fig
drug
includ
inhibitor
molecul
requir
net
format
ne
gasdermin
exampl
endogen
inhibitor
net
format
may
function
inhibit
isol
umbil
cord
plasma
yost
et
al
develop
treatment
inflammatori
syndrom
clinic
develop
inhibitor
ne
advanc
importantli
could
inhibit
format
net
ne
activ
part
signal
mechan
toxic
activ
ne
net
ne
inhibitor
sivelestat
approv
treat
ard
japan
south
korea
increas
surviv
ard
metaanalysi
clinic
trial
tagami
et
al
howev
new
gener
potent
ne
inhibitor
includ
lonodelestat
alvelestat
elafin
undergon
phase
test
result
may
possibl
expedit
develop
treatment
gasdermin
inhibitor
remain
preclin
develop
exist
drugdisulfiram
use
treat
alcoholismha
report
inhibit
gasdermin
limit
lung
injuri
anim
model
hu
et
al
preprint
final
colchicin
anoth
exist
drug
could
inhibit
neutrophil
recruit
site
inflamm
secret
trial
use
colchicin
underway
clinicaltrialsgov
identifi
recombin
dnase
dornas
alfa
deliv
inhal
approv
dissolv
net
airway
patient
cf
clear
mucu
improv
symptom
papayannopoulo
et
al
addit
actinresist
dnase
alidornas
alfa
test
cf
patient
phase
ii
trial
encourag
result
clinicaltrialsgov
identifi
could
potenti
potent
dornas
alfa
engin
dnase
protein
dnase
develop
dissolv
net
fuch
et
al
could
enter
clinic
develop
soon
propos
dnase
may
help
dissolv
mucou
secret
patient
cf
patient
improv
ventil
reduc
risk
secondari
infect
dornas
alfa
normal
administ
nebul
mani
medic
center
avoid
due
risk
aerosol
endang
healthcar
worker
howev
approach
exist
deliv
aerosol
close
circuit
mechan
ventil
patient
dhand
nonintub
patient
therapi
safe
nebul
neg
pressur
room
addit
possibl
effect
mucou
secret
dnase
treatment
may
also
prevent
progress
ard
dnase
deliv
airway
increas
surviv
relev
anim
model
et
al
thoma
et
al
zou
et
al
addit
directli
target
net
loop
could
antagon
approv
drug
anakinra
canakinumab
rilonacept
trial
launch
test
efficaci
anakinra
clinicaltrialsgov
identifi
dornas
alfa
sivelestat
anakinra
excel
safeti
profil
none
drug
current
avail
target
net
specif
nevertheless
collect
multipl
individu
combinatorialand
like
safetherapeut
strategi
avail
antagon
net
patient
today
net
may
appropri
biomark
follow
studi
test
efficaci
net
detect
tissu
immunohistochemistri
blood
sandwich
elisa
caudrilli
et
al
figur
approach
target
net
net
target
exist
drug
sever
mean
ne
gasdermin
inhibitor
prevent
net
format
dnase
use
safe
digest
net
mucou
secret
airway
cf
patient
colchicin
inhibit
neutrophil
migrat
infiltr
site
inflamm
blocker
prevent
inflammatori
loop
net
approach
trial
treat
colchicin
anakinra
alreadi
ongo
launch
clinicaltrialsgov
identifi
et
al
lachowiczscroggin
et
al
park
et
al
sampl
patient
becom
avail
therefor
possibl
determin
whether
presenc
net
associ
sever
result
would
provid
rational
use
abovement
nettarget
approach
treatment
though
treatment
target
net
would
directli
target
viru
could
dampen
outofcontrol
host
respons
therebi
reduc
number
patient
need
invas
mechan
ventil
importantli
reduc
mortal
net
identifi
brinkmann
et
al
often
overlook
driver
sever
pathogen
inflamm
inde
posit
excess
net
may
elicit
sever
multiorgan
consequ
via
known
effect
tissu
immun
vascular
coagul
system
target
net
patient
therefor
consid
biomed
commun
author
member
network
target
neutrophil
thank
andrew
whiteley
organ
discuss
summar
paper
laura
maiorino
gener
illustr
laura
maiorino
stephen
hearn
photomicrograph
net
bruce
stillman
david
tuveson
discuss
critic
review
manuscript
acknowledg
cold
spring
harbor
laboratori
ccsg
microscopi
share
resourc
biorend
use
gener
illustr
figur
apolog
relev
work
includ
discuss
due
space
limit
disclosur
mr
looney
report
neutroli
outsid
submit
work
schwartz
sponsor
advisori
board
member
miromatrix
inc
jd
spicer
report
person
fee
bristol
myer
squibb
person
fee
astra
zeneca
person
fee
merck
person
fee
transhit
bio
nonfinanci
support
astra
zeneca
outsid
submit
work
cc
yost
report
grant
peel
therapeut
inc
conduct
studi
addit
cc
yost
author
us
patent
patent
held
univers
utah
use
netinhibitori
peptid
treatment
prophylaxi
inflammatori
disord
peel
therapeut
inc
exclus
licens
right
egeblad
report
santhera
conduct
studi
consult
cytomx
disclosur
report
submit
april
revis
april
accept
april
